Dr Luke Carter-Brzezinski is a Consultant Haematologist working at the Haematology Cancer Diagnostic Partnership in Manchester, with a particular focus on diagnostics and myeloproliferative disorders.

He completed his MD at the University of Manchester, where his research explored frailty in patients with myeloma. In addition to his clinical practice in the UK, Luke is actively involved in global health initiatives as a member of the British Society of Haematology Global Health Special Interest Group, and has contributed his time to volunteering work overseas.